170 related articles for article (PubMed ID: 11522331)
1. Effects of chronic Delta(9)-tetrahydrocannabinol treatment on hippocampal extracellular acetylcholine concentration and alternation performance in the T-maze.
Nava F; Carta G; Colombo G; Gessa GL
Neuropharmacology; 2001 Sep; 41(3):392-9. PubMed ID: 11522331
[TBL] [Abstract][Full Text] [Related]
2. Hippocampal CB(1) receptors mediate the memory impairing effects of Delta(9)-tetrahydrocannabinol.
Wise LE; Thorpe AJ; Lichtman AH
Neuropsychopharmacology; 2009 Aug; 34(9):2072-80. PubMed ID: 19322169
[TBL] [Abstract][Full Text] [Related]
3. D(2) dopamine receptors enable delta(9)-tetrahydrocannabinol induced memory impairment and reduction of hippocampal extracellular acetylcholine concentration.
Nava F; Carta G; Battasi AM; Gessa GL
Br J Pharmacol; 2000 Jul; 130(6):1201-10. PubMed ID: 10903956
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of hippocampal acetylcholine release after acute and repeated Delta9-tetrahydrocannabinol in rats.
Carta G; Nava F; Gessa GL
Brain Res; 1998 Oct; 809(1):1-4. PubMed ID: 9795096
[TBL] [Abstract][Full Text] [Related]
5. Delta(9)-tetrahydrocannabinol decreases extracellular GABA and increases extracellular glutamate and dopamine levels in the rat prefrontal cortex: an in vivo microdialysis study.
Pistis M; Ferraro L; Pira L; Flore G; Tanganelli S; Gessa GL; Devoto P
Brain Res; 2002 Sep; 948(1-2):155-8. PubMed ID: 12383968
[TBL] [Abstract][Full Text] [Related]
6. Tolerance to the disruptive effects of Delta(9)-THC on learning in rats.
Delatte MS; Winsauer PJ; Moerschbaecher JM
Pharmacol Biochem Behav; 2002 Dec; 74(1):129-40. PubMed ID: 12376160
[TBL] [Abstract][Full Text] [Related]
7. Precipitated cannabinoid withdrawal is reversed by Delta(9)-tetrahydrocannabinol or clonidine.
Lichtman AH; Fisher J; Martin BR
Pharmacol Biochem Behav; 2001; 69(1-2):181-8. PubMed ID: 11420084
[TBL] [Abstract][Full Text] [Related]
8. Reversal of SR 141716A-induced head-twitch and ear-scratch responses in mice by delta 9-THC and other cannabinoids.
Janoyan JJ; Crim JL; Darmani NA
Pharmacol Biochem Behav; 2002; 71(1-2):155-62. PubMed ID: 11812518
[TBL] [Abstract][Full Text] [Related]
9. Delta 9-tetrahydrocannabinol impairs spatial memory through a cannabinoid receptor mechanism.
Lichtman AH; Martin BR
Psychopharmacology (Berl); 1996 Jul; 126(2):125-31. PubMed ID: 8856831
[TBL] [Abstract][Full Text] [Related]
10. (R)-Methanandamide and delta9-tetrahydrocannabinol-induced operant rate decreases in rats are not readily antagonized by SR-141716A.
Järbe TU; Lamb RJ; Liu Q; Makriyannis A
Eur J Pharmacol; 2003 Apr; 466(1-2):121-7. PubMed ID: 12679148
[TBL] [Abstract][Full Text] [Related]
11. Antagonism of the discriminative stimulus effects of delta 9-tetrahydrocannabinol in rats and rhesus monkeys.
Wiley JL; Lowe JA; Balster RL; Martin BR
J Pharmacol Exp Ther; 1995 Oct; 275(1):1-6. PubMed ID: 7562536
[TBL] [Abstract][Full Text] [Related]
12. Opposing actions of chronic Delta9-tetrahydrocannabinol and cannabinoid antagonists on hippocampal long-term potentiation.
Hoffman AF; Oz M; Yang R; Lichtman AH; Lupica CR
Learn Mem; 2007; 14(1-2):63-74. PubMed ID: 17202425
[TBL] [Abstract][Full Text] [Related]
13. Delta-9-tetrahydrocannabinol differentially suppresses cisplatin-induced emesis and indices of motor function via cannabinoid CB(1) receptors in the least shrew.
Darmani NA
Pharmacol Biochem Behav; 2001; 69(1-2):239-49. PubMed ID: 11420092
[TBL] [Abstract][Full Text] [Related]
14. SR 141716A prevents delta 9-tetrahydrocannabinol-induced spatial learning deficit in a Morris-type water maze in mice.
Da S; Takahashi RN
Prog Neuropsychopharmacol Biol Psychiatry; 2002 Feb; 26(2):321-5. PubMed ID: 11817511
[TBL] [Abstract][Full Text] [Related]
15. JWH-018 and JWH-073: Δ⁹-tetrahydrocannabinol-like discriminative stimulus effects in monkeys.
Ginsburg BC; Schulze DR; Hruba L; McMahon LR
J Pharmacol Exp Ther; 2012 Jan; 340(1):37-45. PubMed ID: 21965552
[TBL] [Abstract][Full Text] [Related]
16. Effects of Delta 9-tetrahydrocannabinol, (R)-methanandamide, SR 141716,and d-amphetamine before and during daily Delta 9-tetrahydrocannabinol dosing.
Lamb RJ; Järbe TU; Makriyannis A; Lin S; Goutopoulos A
Eur J Pharmacol; 2000 Jun; 398(2):251-8. PubMed ID: 10854837
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological evaluation of the natural constituent of Cannabis sativa, cannabichromene and its modulation by Δ(9)-tetrahydrocannabinol.
DeLong GT; Wolf CE; Poklis A; Lichtman AH
Drug Alcohol Depend; 2010 Nov; 112(1-2):126-33. PubMed ID: 20619971
[TBL] [Abstract][Full Text] [Related]
18. Long-term cognitive deficits induced by a single, extremely low dose of tetrahydrocannabinol (THC): behavioral, pharmacological and biochemical studies in mice.
Senn R; Keren O; Hefetz A; Sarne Y
Pharmacol Biochem Behav; 2008 Jan; 88(3):230-7. PubMed ID: 17888506
[TBL] [Abstract][Full Text] [Related]
19. Involvement of reduced acetylcholine release in Delta9-tetrahydrocannabinol-induced impairment of spatial memory in the 8-arm radial maze.
Mishima K; Egashira N; Matsumoto Y; Iwasaki K; Fujiwara M
Life Sci; 2002 Dec; 72(4-5):397-407. PubMed ID: 12467880
[TBL] [Abstract][Full Text] [Related]
20. Delta(9)-tetrahydrocannabinol increases endogenous extracellular glutamate levels in primary cultures of rat cerebral cortex neurons: involvement of CB(1) receptors.
Tomasini MC; Ferraro L; Bebe BW; Tanganelli S; Cassano T; Cuomo V; Antonelli T
J Neurosci Res; 2002 May; 68(4):449-53. PubMed ID: 11992471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
